Skip to main content
Caplight Logo









Sola Diagnostics GmbH

Sola Diagnostics GmbH

Private
InnsbruckHealthcare & Life Scienceshttps://sola-diagnostics.com/

Last Round

Grant

Aug 1, 2025

Total Funding Raised

$3.98M

Company Overview

Sola Diagnostics GmbH is a biotechnology company that develops and markets minimally invasive epigenetic diagnostic tools for the early detection and prevention of women's cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

blood-based biomarkerParkinson's diseasediagnostic assayliquid biopsyneurodegenerative diseasemolecular diagnosticsearly detectionclinical laboratorymovement disordersin-vitro diagnosticsIVDbiotechprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sola Diagnostics GmbH Comparables

Compare Sola Diagnostics GmbH with similar companies based on industry and business-model similarity.

Sola Diagnostics GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Myriad Genetics
52%
Shanghai Epiprobe Biotechnology Co., Ltd.
52%
Ziwig Biotech
47%

Sola Diagnostics GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 1, 2025

Key People

Founding team and executive leadership

Peter Kayatz

Chief Executive Officer

Executive Team

Peter Ince

COO

Executive Team

Sola Diagnostics GmbH Investors

Notable investors and investment history

Sola Diagnostics GmbH investors
InvestorRounds
University of InnsbruckConvertible Debt
National Institute for Health and Care ResearchGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 38% MoM.

  • Jan 6, 2026

    Monthly visitors grew 63% MoM.

Sola Diagnostics GmbH Filings

Explore SEC and related filing metadata, where available.

Sola Diagnostics GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sola Diagnostics GmbH's valuation, stock price, and market status.

Is Sola Diagnostics GmbH a public or private company?

Sola Diagnostics GmbH is a private company.

What is the current stock price of Sola Diagnostics GmbH?

Sola Diagnostics GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Sola Diagnostics GmbH worth (valuation)?

Valuation information for Sola Diagnostics GmbH is not publicly available.

Can I buy Sola Diagnostics GmbH stock?

Sola Diagnostics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sola Diagnostics GmbH's last funding round?

Sola Diagnostics GmbH's most recent funding round was Grant on August 1, 2025.

Who are the main investors in Sola Diagnostics GmbH?

Key investors in Sola Diagnostics GmbH include University of Innsbruck, National Institute for Health and Care Research.

Will Sola Diagnostics GmbH IPO soon?

No public IPO plans have been announced for Sola Diagnostics GmbH.

How can I track Sola Diagnostics GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sola Diagnostics GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersInnsbruck
Employee Range7
Year Founded2020
Last FundingAug 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?